Overview

Everything registered for Conexeu in 00-admin/artifacts.json, generated from the approved PreWiki projection

Overview

One page. If a deliverable breaks any of these, it does not ship.

Regulatory (hardest)

1. No outcome claim. designed to / intended to / may support: never restores, proves, works,

Color

7. Conexeu Green is #0E443A. Not #0F574A (guide caption typo), not #042A23 (a live-site

Type

12. Two families only: IvyPresto Display (Thin / Light, italic for emphasis) and Neue Montreal.

Mark

16. Clearspace = the height of the X, on all sides, both marks.

Devices

20. One device per composition: Mesh or X Pattern, not both.

Overview

The master index for the Conexeu visual system. Canon is the Figma file

The system in one paragraph

White and Conexeu Green #0E443A are the whole field. Secondary greens add depth but never

Layout system

Print / artboard (from the guide's own slide construction):

• Working artboard 1920 × 1080. Content sits on a white page inset inside the green field,
• Slide chrome: 14pt Neue Montreal Regular running head (Conexeu Brand Guidelines), section number
• Section title 53pt IvyPresto Thin; section divider 75pt; number 33pt.
• Two-column body: rule copy in ~641pt-wide columns at 14pt.
• Containers 82.5rem / large 95.625rem / medium 106.875rem; page width 1600px;
• Section gap 8.125rem; section-with-content top 7.5rem, bottom 7.4375rem, middle 3.0625rem.
• Radii 15 / 20 / 30px (small / medium / large).
• Eyebrow ("sub-heading") 12px at 0.0875rem tracking above h1/h2.

The card pattern (guide 4.5, and the one reusable composition)

The "Architects of …" card is the system's canonical unit and it is what social and deck templates

Overview

> The 2026 brand guide does not contain a voice. Sections 1.1 Brand Overview, 1.2 Brand

Positioning

Architecting Bioregeneration™: the trademarked positioning line, and the organising metaphor for

The register: design, not outcome

This is the single most important rule and it is a legal one as much as a stylistic one. Conexeu

• "Our CXU scaffold is designed to provide a temporary structural environment that may support
• "CXU™ is being evaluated as a bioregenerative scaffold designed to provide structural support…"
• "This is the gap Conexeu is designed to address."

Sentence architecture

architecture, blueprint, remodeling, integration, migration, ingrowth.

• Structural nouns carry the meaning: scaffold, extracellular matrix, ECM, structure, foundation,
• Short declaratives, then one long explanatory sentence. "Every tissue in the human body depends
• Triads for the platform claim. "One platform, one formula, one device." / "CXU™ is one
• Questions as section openers. "What is Bioregeneration?" · "What makes bioregeneration
• Second-person only when the subject is the reader's body. "Understanding your tissue is the
• Unhurried. No exclamation, no hype adverbs, no startup idiom.

The naming system

Architects of {vertical} is the live page-title pattern and the card pattern in the guide (4.5).

Trademarks and names: exact strings

Inc." with a comma; www does not. www wins.

• Legal name: Conexeu Sciences Inc. (no comma). ir.conexeu.com publishes "Conexeu Sciences,
• Ticker: Nasdaq: CNXU.
• Marks, verbatim from the site's own notice: "CXU™, Ten-Minute Tissue™, B.R.E.A.S.T.™ and
• Ten-Minute Tissue™ is hyphenated and does appear on www (12 occurrences). B.R.E.A.S.T.™ keeps
• Copyright line: © 2026 Conexeu. All Rights Reserved.
• Competitor marks (Ozempic®, Wegovy®, Dysport®, Sculptra®, Restylane®, Radiesse®, Xeomin®,

Overview

> SUPERSEDED 2026-08-21. Canon now lives at PreWiki/Clients/Conexeu/Brand Instructions/brand.md,

Who

Conexeu Sciences Inc. (Nasdaq: CNXU). Preclinical-stage regenerative tissue platform developing

Regulatory status: read this before writing anything

CXU™ is an investigational device and is not cleared or approved for any use. Every asset must

• No results, outcomes, timelines or percentages. No before-and-after in any form.
• No testimonials, patient, customer or practitioner.
• Verbs stay in the design register: designed to, intended to, supports. Never restores,
• Investigational-status line at first substantive mention, not only in a footer.
• No comparative claims against named competitor products.

Colour

Ground is dark teal green #042A23; the light surface is pearl #F8F7F3. Accent is

Type

IvyPresto Display for display and headlines (weights 100: 400, tight 110% leading).

Imagery

Signature visual is macro ECM microstructure: white fibrous scaffold over coral/peach adipose

Overview

Append-only. Every row was read off the live post on the date shown, so a row stays

Overview

First presignal run. This is also the run the skill was extracted from, so the methodology

Asked

A Conexeu-branded interactive social + SEO/AEO plan: deep dive on conexeu.com and its

Read

Twenty posts read off live feeds on 2026-08-20: nine Instagram, eleven LinkedIn. Full rows in

Concluded

1. The ceiling format in this category is a sub-dermal mechanism animation.

Recommended

Five formats ranked, with the mechanism film first (highest ceiling) and the macro material

Still open

blue/green/pink palette. The live site runs dark-teal-green + gold with IvyPresto Display and

• Brand canon conflict. The Nov-2025 brand guide specifies PP Neue Montreal with a
• /platform/in-work---aesthetics-cxu is published and publicly reachable, titled "IN
• Comparator macro frames. The vault holds macro shots of CXU beside named competitor
• TikTok decision memo unsigned. Recommendation is defer (see category findings), but the
• No brand.md in Brand Instructions/, so presocial cannot see this client. A first
• Thin Oracle brain. Only source-map.md exists, no 02-foundation, 03-brand,

Social: read 2026-08-20

a link, 32 engagements = 7.0 per 1k.

• LinkedIn: 4,565. A separate "AROA ECM" product showcase page carries 1,315.
• Best post found: "Minimal complications. Maximum confidence.", three clinical bullets and
• Default format: text + link, clinical-publication register. No mechanism visual anywhere.
• Where they are open: this is the closest company in the world to a CXU-style structural

Social: read 2026-08-20

@sculptrabygalderma 40,000. LinkedIn: 558,848.

• Instagram: @aestheticsbygalderma 76,400 (follows 8, pure broadcast);
• Best post found: animated cross-section through epidermis / dermis / hypodermis,
• Default format: results and lifestyle. The mechanism animation is an outlier they proved
• Where they are open: "regenerative biostimulator" is doing heavy lifting for a

Social: read 2026-08-20

No official TikTok account found.

• Instagram: @myrenuva 13,600, follows 4,528, i.e. deliberate reciprocal-follow growth.
• Best post found: practitioner Q&A reels are the recognisable format; nothing read above
• Default format: practitioner and patient results, plus an "elite injector" scarcity frame.
• Where they are open: no mechanism animation despite selling an adipose matrix, the most

Overview

Production-facing. Pairs with ../03-brand/brand-non-negotiables.md.

Do

Hydra for oral health, Coral for aesthetics, Rose for animal health, CXU green for 3D bioprinting.

• Start from white or Conexeu Green #0E443A. Decide the ground first; the rest of the system follows.
• Let one therapeutic family own a piece when the piece is about one vertical, Iris for wound care,
• Set display in IvyPresto Thin or Light, and put emphasis in Light Italic.
• Use the Frame. It is the cheapest, most recognisable Conexeu signal there is: 1.5% of the
• Let the Mesh follow the form of whatever it overlays, that contour behaviour is the idea.
• Keep gold to hairlines, rules and small details, on green or white.
• Build the "Architects of …" card when you need a repeatable unit: frame, solid panel, IvyPresto
• Write in the design register and put the investigational line in the asset.

Don't

never the 1 or 2 stops as a background.

• No blue, pink or charcoal from the Nov-2025 guide. That system is dead.
• No #0F574A and no #042A23 standing in for Conexeu Green in print or social.
• No gold on a secondary green. No gold as a surface.
• No therapeutic colour as a full-bleed background outside infographics and multi-page documents, and
• No body copy on CG 3, CG 4, Coral 2, Rose 1, Rose 2 or Slate 3, measured contrast fails.
• No third typeface, no bold IvyPresto, no all-caps headline, no live-text positioning line.
• No Mesh and X Pattern in the same composition. No full-surface X Pattern.
• No gradient, blur, drop shadow, bevel, glow or 3D extrusion on any brand element.

Overview

Read this before writing a single word of Conexeu-facing copy. CXU™ is a preclinical,

The status, verbatim from conexeu.com

> IMPORTANT NOTICES: CXU™ is a medical device candidate in preclinical development. It has not

Hard rules

1. No outcome claims. Nothing that says or implies CXU™ regenerates, restores, heals, works or

Why TikTok and short-form consumer video stay closed

Recorded in 06-content-social/ and restated here because it keeps getting re-litigated: FDA's

The one boilerplate to paste

For any asset that makes a substantive claim about CXU™:

Escalate, don't guess

If a piece needs a number, a result, a timeline or a practitioner's words, stop and ask. There is no